Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Project Oncology®Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Shelina Ramnarine, PhD
John Mascarenhas, MD
Marina Kremyanskaya, MD
Recognizing Atypical Presentations of Inflammatory Dermatoses
DermConsultRecognizing Atypical Presentations of Inflammatory Dermatoses
Alexandria May, PharmD, BCPS
Naiem T. Issa, MD, PhD, FAAD
The Long Road to an FCS Diagnosis
On the Frontlines of Familial Chylomicronemia SyndromeThe Long Road to an FCS Diagnosis
Charles Turck, PharmD, BCPS, BCCCP
Peter P. Toth, MD, PhD, FAAFP, FICA, FAHA, FNLA, FCCP, FACC
Could It Be FCS? Recognizing the Diagnostic Clues
On the Frontlines of Familial Chylomicronemia SyndromeCould It Be FCS? Recognizing the Diagnostic Clues
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Zahid Ahmad, MD, FNLA
Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
Project Oncology®Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
Charles Turck, PharmD, BCPS, BCCCP
Douglas A. Tremblay, MD
Understanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses
DermConsultUnderstanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses
Charles Turck, PharmD, BCPS, BCCCP
David Cotter, MD, PhD
- advertisement
Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
CME/CEHypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
Dolores Shoback, MD
Michael T. Collins, MD
Overcoming Challenges in Transthyretin Cardiac Amyloidosis
CME/CEOvercoming Challenges in Transthyretin Cardiac Amyloidosis
Mathew S. Maurer, MD
Jan M. Griffin, MD
Frederick Ruberg, MD
Raising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice
CME/CERaising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice
Alex F. Herrera, MD
AACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
CME/CEAACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
Susan L Samson, MD, PhD, FRCPC, FACE
Lawrence Blonde, MD, FACP, FACE
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
CME/CESjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Chadwick R. Johr, MD
Case Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
CME/CECase Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
Carole Bitar, MD, FAAD
Matthew P. Giannetti, MD
Benjamin Ungar, MD
- advertisement
Understanding CIDP: Disease Heterogeneity and Diagnostic Challenges
Medical Industry FeatureUnderstanding CIDP: Disease Heterogeneity and Diagnostic Challenges
Jennifer Caudle, DO, FACOFP
Allison Crowell, MD
Advancing Care in Chronic GVHD: Evolving Therapeutic Insights
Project Oncology®Advancing Care in Chronic GVHD: Evolving Therapeutic Insights
Brian P. McDonough, MD, FAAFP
Brooke Adams, PharmD, BCOP
Exploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Medical Industry FeatureExploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Brian P. McDonough, MD, FAAFP
Julie Paik, MD, MHS
Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Medical Industry FeatureIdentifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Sandhya Panch, MD, MPH
The Corticosteroid Journey in PMR: Understanding the Patient Experience
Medical Industry FeatureThe Corticosteroid Journey in PMR: Understanding the Patient Experience
Charles Turck, PharmD, BCPS, BCCCP
Rodney Daniel, MD
Grace C Wright, MD, PhD, FACR
Expanding Treatment Options in PNH: Expert Approaches to Personalized Care
Medical Industry FeatureExpanding Treatment Options in PNH: Expert Approaches to Personalized Care
Caroline Piatek, MD
Bhumika Patel, MD